Drug: sorafenib Quarter: 2016Q3
Total Records: 167 Number of Pages: 9
DRUGNAME | PT | EventCount |
---|---|---|
SORAFENIB (RAF KINASE INHIBITOR) | Haematuria | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Hepatic vein stenosis | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Hyperthyroidism | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Hypogammaglobulinaemia | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Hypothyroidism | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Lymphadenitis bacterial | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Myocardial infarction | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Nephrotic syndrome | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Pain | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Proteinuria | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Rash maculo-papular | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Salivary gland cancer | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Squamous cell carcinoma of lung | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Thrombotic microangiopathy | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Tracheo-oesophageal fistula | 1 |
SORAFENIB (RAF KINASE INHIBITOR) | Venoocclusive liver disease | 1 |
SORAFENIB, 200 MG | Lipase increased | 1 |
SORAFENIB, 200 MG BAYER | Lipase increased | 1 |
SORAFENIB, 200 MG BAYER | Odynophagia | 1 |
SORAFENIB, 200 MG BAYER | Oedema | 1 |
Total Records: 167 Number of Pages: 9